Menu
ncarol.com
  • Home
  • Education
  • Health
  • Books
  • Technology
  • Financial
  • Entertainment
  • Real Estate
  • Music
ncarol.com

North Carolina: Biopharmaceutical Manufacturer Merck Expands Again in Wilson County with $57 Million Investment
ncarol.com/10036934

Trending...
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
Merck (NYSE: MRK), a leading global biopharmaceutical company, will invest $57 million and create 55 jobs in Wilson, Governor Roy Cooper announced today. The expansion will establish a filling and packaging line for the company's RotaTeq® vaccine.

"Merck is a cornerstone of pharmaceutical development and manufacturing, and good jobs will continue to grow with today's announcement in Wilson," said Governor Cooper.

Merck, with headquarters in Kenilworth, New Jersey and known as MSD outside of the United States and Canada, discovers and develops medicines and vaccines for many of the world's most challenging diseases.  The company operates in more than 140 countries and stays at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world.

The company's RotaTeq® vaccine is used to prevent rotavirus gastroenteritis in children. Rotavirus gastroenteritis can cause fever, vomiting and diarrhea that can be severe and lead to dehydration and hospitalization. Merck's investment at the Wilson site will increase the company's overall supply of this important medicine.

"Merck is delighted to announce its second significant investment at our Wilson plant in less than a year," said Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division. This latest commitment will enable us to introduce a new and innovative filling and packaging technology to assist in the production of our important RotaTeq® vaccine. We appreciate all the support we've received for this project from Governor Cooper, Secretary Copeland and his staff, and from Wilson County."

More on ncarol.com
  • Ailias Launches Global Partner Programme for AI-Powered Conversational Digital Humans in Events and Experiences
  • Village People Headline "Rock The Rainbow" Phuket Pride Finale 2026
  • SilverBow Strategies Launches RFPArchon™, the First Product in Its Artemis AI Solutions™ Suite
  • New from Regal House Publishing, The Unfinished Business, its tricky inheriting a ghost-busting firm
  • Sawasdee Anime Launches Animenture: A Gamified SNS Connecting Global Fans to 2,000+ Anime Sites

Today's commitment is the second major expansion Merck has announced in North Carolina in 2019. In July, the company announced it would begin producing its GARDASIL® and GARDASIL 9® recombinant human papillomavirus (HPV) vaccine in the state, supported by expansion of company facilities in Durham and Wilson. In the earlier announcement, the company committed to invest more than $680 million in the state, with $30 million of that investment earmarked for Wilson.

"Nothing beats first-hand knowledge, and Merck's previous experience in our state gave them the confidence to bring this new business line here," said North Carolina Commerce Secretary Anthony M. Copeland.  "In just one year, this company has now invested $737 million in North Carolina, proving again that we're a hotbed for the life science industry."

The North Carolina Department of Commerce led the state's support for the company during its site evaluation and decision-making process.

Although wages will vary depending on position, Merck's average salary for all the new positions will reach $59,273. The current average wage in Wilson County is $44,012.

A performance-based grant of $200,000 from the One North Carolina Fund will help facilitate Merck's expansion in Wilson County. The One NC Fund provides financial assistance to local governments to help attract economic investment and to create jobs. Companies receive no money upfront and must meet job creation and capital investment targets to qualify for payment. All One NC grants require a matching grant from local governments and any award is contingent upon that condition being met.

More on ncarol.com
  • "LOOK UP CAFE TOKYO SKYTREE" to Open on May 22, 2026 on the 5th floor of TOKYO SKYTREE®. This Date also Marks TOKYO SKYTREE's 14th Anniversary
  • "Rehabilitative Prison Program Compromised by Alleged Staff Misconduct, Whistleblower Claims"
  • Creator Space LA brings together industry leaders for an immersive AI showcase, demonstrations, and film hackathon
  • The Hardest Part of Building an App Isn't Starting - It's Finishing
  • Uxur Taxi Unveils Luxury 3,000‑Mile Private Driver Service for Nationwide Travel

"Merck is a valued employer in our region," said N.C. Senator Milton 'Toby' Fitch, Jr. "We welcome these additional jobs and the opportunities they will bring to our people."

"New growth from one of our area's most important industries is an exciting development," said N.C. Representative Jean Farmer-Butterfield. "Our community is proud to partner with Merck and we look forward to supporting the company's next phase of growth."

Partnering with N.C. Commerce and the Economic Development Partnership of North Carolina on this project were the North Carolina General Assembly, Wilson County, and the Wilson County Economic Development Office.

Filed Under: Government, State

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Now Presenting Flights of Fancy
  • Card makers turn to Pink and Main for tools to support their craft
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
  • EduCare Inc. Bridges Critical Gap in Breast Cancer Education with Spanish COPE Library Launch
  • Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Grange Insurance Association to Rebrand as Granwest Insurance on July 1, 2026
  • Dr. Rosendo Icochea, MD Recognized for Contributions to Surgical Education and Medical Research
  • Giftella Launches AI Gift-Finder App That Replaces Guesswork With Personalized Picks in Seconds
  • Beverly.io Announces Nationwide Expansion and Poppins Payroll Partnership for Families
  • New Book: The Battle for Truth and Shadows - Guardians of Light - Epic Fantasy Unveils a War Between Light and Deception
  • Comfortable Clothing for Every Moment
  • Clash of Prompts: The World's First AI Prompt Battle Royale
  • $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
  • MainConcept Announces Multiview Encoding for Apple Immersive Video
  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
  • Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
_catLbl0 _catLbl1

Popular on ncarol.com

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 360
  • Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets - 146
  • Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
  • UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
  • Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry

Similar on ncarol.com

  • SilverBow Strategies Launches RFPArchon™, the First Product in Its Artemis AI Solutions™ Suite
  • Contracting Resources Group and Aalis Management Consulting Launch ARG Joint Venture Under SBA Mentor-Protégé Program
  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
  • Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
  • Radarsign™ Awarded Sourcewell Contract Expanding Access to Traffic Safety Solutions
  • Mac Mountain Selects netElastic vRouter for LightCraft Broadband-as-a-Service Platform
  • Congressional Roundtable Exposes Mental Health Crisis: More Spending and Treatment, Worse Results – CCHR Demands Accountability
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
  • CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute